AVBP
ArriVent BioPharma, Inc. · Healthcare · Biotechnology
Input momentum (manajer yang sebanding):
keluasan pemegang +7.7% ·
aliran saham +30.0% ·
posisi baru bersih +7.1%
· formula
Akumulasi luas: saham yang meningkat di lebih banyak pemegang
Semua angka kepemilikan: hanya manajer 13F yang dipantau, posisi saham biasa, periode pelaporan Q3 2025
| Kuartal | Pemegang | Δ | Saham | Nilai yang dilaporkan | Baru | Keluar |
|---|---|---|---|---|---|---|
| Q3 2026 | 1 | +1 | 67.09K | $2.03M | +1 | n/a |
| Q2 2026 | 67 | +6 | 17.31M | $600.66M | +10 | −4 |
| Q1 2026 | 63 | +7 | 15.17M | $349.66M | +10 | −3 |
| Q4 2025 | 56 | +3 | 14.51M | $292.04M | +3 | n/a |
| Q3 2025 | 14 | +1 | 10.75M | $198.25M | +2 | −1 |
| Q2 2025 | 10 | 0 | 7.02M | $152.80M | +2 | −2 |
| Q1 2025 | 7 | +1 | 1.69M | $31.28M | +2 | −1 |
| Q4 2024 | 6 | -1 | 1.52M | $40.62M | +1 | −2 |
| Q3 2024 | 6 | +4 | 925.82K | $21.76M | +4 | n/a |
| Q2 2024 | 2 | n/a | 247.05K | $4.58M | n/a | n/a |
| # | Manajer | Saham | Δ saham | Nilai | Bobotnya | Dipegang | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Fidelity (FMR) ✦ | 3.41M | +65.6% | $62.87M | 0.0% | ▲ Add | 2 | SEC ↗ ×2 |
| 2 | BlackRock ✦ (pasif) | 2.05M | +11.3% | $37.75M | 0.0% | ▲ Add | 2 | SEC ↗ ×11 |
| 3 | The Vanguard Group ✦ (pasif) | 2.03M | +36.8% | $37.44M | 0.0% | ▲ Add | 2 | SEC ↗ ×5 |
| 4 | State Street Global Advisors ✦ (pasif) | 1.03M | +38.7% | $18.96M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 5 | Geode Capital Management ✦ (pasif) | 716.29K | +20.2% | $13.22M | 0.0% | ▲ Add | 6 | SEC ↗ ×2 |
| 6 | Goldman Sachs Group ✦ | 431.94K | n/a | $7.97M | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 7 | Morgan Stanley ✦ | 392.02K | n/a | $7.23M | 0.0% | n/c | 1 | SEC ↗ ×7 |
| 8 | Millennium Management ✦ | 286.10K | +62.4% | $5.28M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 9 | Marshall Wace ✦ | 180.22K | Baru | $3.33M | 0.0% | New | 1 | SEC ↗ ×3 |
| 10 | Two Sigma Investments ✦ | 91.72K | Baru | $1.69M | 0.0% | New | 1 | SEC ↗ |
| 11 | Wellington Management ✦ | 81.75K | +23.2% | $1.51M | 0.0% | ▲ Add | 4 | SEC ↗ ×3 |
| 12 | JPMorgan Chase ✦ | 27.98K | n/a | $516,268 | 0.0% | n/c | 1 | SEC ↗ ×6 |
| 13 | T. Rowe Price ✦ | 14.36K | +25.3% | $265,000 | 0.0% | ▲ Add | 5 | SEC ↗ |
| 14 | AQR Capital Management ✦ | 11.82K | -17.5% | $218,134 | 0.0% | ▼ Trim | 2 | SEC ↗ ×5 |
"Their weight" = porsi posisi dari nilai ekuitas 13F yang dilaporkan manajer tersebut: ukuran keyakinan. ✦ = manajer yang dikurasi.
Pembeli baru
| Marshall Wace | $3.33M | 0.0% |
| Two Sigma Investments | $1.69M | 0.0% |
Telah keluar
| Citadel Advisors | $732,669 | adalah 0.0% |
Konteks pasar penuh: di SEMUA filer 13F (data terstruktur SEC, Q1 2026): 138 pemegang, 42.02M saham, $965.37M dilaporkan. Ini adalah periode berbeda yang lebih lama dibandingkan angka semesta yang dilacak di atas, dan keduanya tidak pernah dicampur.
Apa lagi yang paling sering dimiliki oleh pemegang sekuritas ini yang dilacak: jumlah kepemilikan bersama, bukan hubungan fundamental.